23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Sharma M, Castro-Piedras I, Rasha F, Ramachandran S, Sennoune SR, Furr K, Almodovar S, Ganapathy V, Grisham MB, Rahman RL, Pruitt K. Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling. Oncotarget. 12: 2234-2251. PMID 34733415 DOI: 10.18632/oncotarget.28089  0.325
2021 Sharma M, Castro-Piedras I, Rodgers AD, Pruitt K. Genomic profiling of DVL-1 and its nuclear role as a transcriptional regulator in triple negative breast cancer. Genes & Cancer. 12: 77-95. PMID 34659647 DOI: 10.18632/genesandcancer.217  0.325
2021 Castro-Piedras I, Sharma M, Brelsfoard J, Vartak D, Martinez EG, Rivera C, Molehin D, Bright RK, Fokar M, Guindon J, Pruitt K. Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth. Embo Reports. e50600. PMID 33860601 DOI: 10.15252/embr.202050600  0.358
2020 Castro-Piedras I, Vartak D, Sharma M, Pandey S, Casas L, Molehin D, Rasha F, Fokar M, Nichols J, Almodovar S, Rahman RL, Pruitt K. Identification of Novel MeCP2 Cancer-Associated Target Genes and Post-Translational Modifications. Frontiers in Oncology. 10: 576362. PMID 33363010 DOI: 10.3389/fonc.2020.576362  0.441
2019 Sharma M, Molehin D, Castro-Piedras I, Martinez EG, Pruitt K. Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer. Scientific Reports. 9: 16257. PMID 31700102 DOI: 10.1038/s41598-019-52723-3  0.348
2018 Castro-Piedras I, Sharma M, den Bakker M, Molehin D, Martinez EG, Vartak D, Pruitt WM, Deitrick J, Almodovar S, Pruitt K. DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells. Oncotarget. 9: 35639-35654. PMID 30479694 DOI: 10.18632/oncotarget.26257  0.327
2018 Pruitt K, Molehin D, Castro-Piedras I, Sharma M, R Sennoune S, Arena D, Manna PR. Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition. Molecular Cancer Research : McR. PMID 29921733 DOI: 10.1158/1541-7786.MCR-18-0047  0.333
2016 Pandey S, Pruitt K. Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon and prostate. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. PMID 28177766 DOI: 10.1139/bcb-2016-0154  0.321
2016 Pruitt K. Molecular and Cellular Changes During Cancer Progression Resulting From Genetic and Epigenetic Alterations. Progress in Molecular Biology and Translational Science. 144: 3-47. PMID 27865461 DOI: 10.1016/bs.pmbts.2016.09.001  0.323
2015 Saxena M, Dykes SS, Malyarchuk S, Wang AE, Cardelli JA, Pruitt K. The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration. Oncogene. 34: 188-98. PMID 24362520 DOI: 10.1038/Onc.2013.549  0.426
2014 Simmons GE, Pandey S, Nedeljkovic-Kurepa A, Saxena M, Wang A, Pruitt K. Frizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells. Plos One. 9: e98861. PMID 24897117 DOI: 10.1371/journal.pone.0098861  0.374
2014 Soung YH, Pruitt K, Chung J. Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells. Scientific Reports. 4: 3846. PMID 24457910 DOI: 10.1038/srep03846  0.306
2013 Holloway KR, Barbieri A, Malyarchuk S, Saxena M, Nedeljkovic-Kurepa A, Cameron Mehl M, Wang A, Gu X, Pruitt K. SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression. Molecular Endocrinology (Baltimore, Md.). 27: 480-90. PMID 23340254 DOI: 10.1210/me.2012-1347  0.301
2010 Holloway KR, Calhoun TN, Saxena M, Metoyer CF, Kandler EF, Rivera CA, Pruitt K. SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. Proceedings of the National Academy of Sciences of the United States of America. 107: 9216-21. PMID 20439735 DOI: 10.1073/pnas.0911325107  0.341
2007 Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genetics. 39: 237-42. PMID 17211412 DOI: 10.1038/Ng1972  0.703
2007 Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Research. 67: 194-201. PMID 17210699 DOI: 10.1158/0008-5472.Can-06-3396  0.697
2006 Pruitt K, Zinn RL, Ohm JE, McGarvey KM, Kang SH, Watkins DN, Herman JG, Baylin SB. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. Plos Genetics. 2: e40. PMID 16596166 DOI: 10.1371/Journal.Pgen.0020040  0.699
2005 Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. The Journal of Biological Chemistry. 280: 23363-70. PMID 15831492 DOI: 10.1074/Jbc.M503083200  0.654
2002 Pruitt K, Pruitt WM, Bilter GK, Westwick JK, Der CJ. Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation. The Journal of Biological Chemistry. 277: 31808-17. PMID 12082106 DOI: 10.1074/Jbc.M203964200  0.612
2002 Shields JM, Mehta H, Pruitt K, Der CJ. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Molecular and Cellular Biology. 22: 2304-17. PMID 11884615 DOI: 10.1128/Mcb.22.7.2304-2317.2002  0.666
2001 Pruitt K, Der CJ. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Letters. 171: 1-10. PMID 11485822 DOI: 10.1016/S0304-3835(01)00528-6  0.644
2000 Pruitt K, Pestell RG, Der CJ. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. The Journal of Biological Chemistry. 275: 40916-24. PMID 11007784 DOI: 10.1074/Jbc.M006682200  0.646
2000 Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: 'it ain't over 'til it's over'. Trends in Cell Biology. 10: 147-54. PMID 10740269 DOI: 10.1016/S0962-8924(00)01740-2  0.604
Show low-probability matches.